Don J. Perez Ortiz, M.D., F.A.C.S.

Certification

American Board of Ophthalmology

Education

High School Jesuit High School, Tampa, FL
Graduated in 1973

College University of South Florida, Tampa, Florida
September 1973 - June 1975
Major: Biology

Medical School Universidad Central del Este,
San Pedro de Macoris, Dominican Republic
September 1975 - May 1980
Degree: M.D.

Post Graduate Training

Catholic Medical Center of
Brooklyn and Queens, Jamaica, NY
Internal Medicine
July 1980 - July 1981

Residency Catholic Medical Center of
Brooklyn and Queens, Jamaica, NY
PGY-2 Ophthalmology
July 1981 - June 1982

Catholic Medical Center of
Brooklyn and Queens, Jamaica, NY
PGY-3 Ophthalmology
July 1982 - June 1983

Catholic Medical Center of
Brooklyn and Queens, Jamaica, NY
PGY-4 Ophthalmology
July 1983 - June 1984

Fellowship State University of New York (SUNY)
Downstate Medical Center, Brooklyn, NY
PGY- 5 Retina Fellow
July 1984 - April 1985

Community/Faculty Appointments

Official Ophthalmologist for the NFL, Tampa Bay Buccaneers, August 2000 - present

Assistant Chief of Staff, Department of Ophthalmology; Tampa General Hospital, Tampa, FL, 1985 - present

Clinical Assistant Professor, University of South Florida, College of Medicine; Department of Ophthalmology, Tampa, FL, June 1990 – present

General Ophthalmologist Advisory Board; Pfizer, Inc.; January 2004 - present

Hospital Affilations

Active Staff Tampa General Hospital, Tampa, FL
Assistant Chief of Staff, Department of Ophthalmology
1985 - Present

Active Staff St. Joseph's Hospital, Tampa, FL
1985 - Present

Active Staff University Community Hospital, Tampa, FL
1985 - Present

Active Staff Tampa Outpatient Surgery, Tampa, FL
1985 - Present

Courtesy H. Lee Moffitt Cancer Center &
Research Institute, Tampa, FL
1985 - Present

Courtesy Town & Country Hospital
IASIS Healthcare, Tampa, FL
1985 - Present

Courtesy Vencor Hospital, Tampa, FL
1985 - Present

Health Related Organizations

American Board of Ophthalmology (Diplomat)

Fellow American College of Surgeons

American Academy of Ophthalmology (Diplomat)

The International Society of Ocular Surgeons

Assistant Clinical Professor,
University of South Florida,
Ophthalmology Department

Hillsborough County Medical Association

Florida Medical Association

The Vitreous Society

Research to Prevent Blindness

Pan American Association of Ophthalmology

American Medical Association -

Diabetic Retinopathy Clinical Research Network

Awards
Physician’s Recognition Award, American Medical Association, 1990, 1992

Bibliography

Abstracts Presented:

Perez Ortiz DJ: Initial Experience with Hydroview II, Annual Meeting of the Hungarian Ophthalmology Society; 2003

Clinical Research Projects:

Studies of the Molecular Genetics of the Eye: Sponsor: Cleveland Clinic. Sub-Investigator

Multi-Center, Randomized, Double-Masked, Parallel Study to Compare the Safety and Efficacy of 0.3% Gatifoxacin Ophthalmic Solution With That of 0.3% Ofloxacin Ophthalmic Solution in The Treatment of Acute Bacterial Conjunctivitis: SPCL-GFLX 3/02: Sponsor: Senju/Allergan Sub-Investigator

Multicenter, Double-Masked, Randomized, 3-Arm Parallel Study, For 3 Months (With A 9-Month, Masked Extension) Of The Safety And Efficacy Of Bimatoprost 0.03%/Timolol 0.5% Combination Ophthalmic Solution Once Daily Compared With Timolol 0.5% Monotherapy Twice Daily And Bimatoprost 0.03% Monotherapy Once Daily In Patients With Glaucoma Or Ocular Hypertension: 192024-021T: Sponsor: Allergan: Sub-Investigator

A Randomized, Multi-Center Comparison of the Aqueous Humor Concentration of Loteprednol Etabonate Following Administration of Bausch & Lomb, Inc Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3% or Lotemax® (loteprednol etabonate ophthalmic suspension, 0.5%) During Routine Cataract Surgery. BLP 358-006; Sponsor: Bausch & Lomb, Inc. Principal Investigator

A Prospective, Multicenter, Open Label Study To Evaluate The Overall Clinical And Patient Acceptance Of The Hyroview“ Hp60m Intraocular Lens In Patients Undergoing Routine Cataract Surgery: CAT: Sponsor: Bausch & Lomb, Inc., Pilot Study Sub-Investigator

A Multi-Center, Randomized, Double Masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide (0.5 or 2 mg) Implant in Patients with Non Infectious Uveitis Affecting the Posterior Segment of the Eye. Sponsor: Bausch & Lomb, Inc. . Principal Investigator

A comparison of CIPRODEX (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Ophthalmic Suspension, versus CILOXAN® (Ciprofloxacin 0.3%) Ophthalmic Solution, MAXIDEX ® (Dexamethasone 0.1%) Ophthalmic Suspension and CIPRODEX Vehicle for Treatment of Bacterial Blepharitis. C-02-52 Sponsor: Alcon Research Ltd Sub-Investigator

A Three-Month, Randomized, Double-Masked, Parallel Group, Primary Therapy Study with a Planned Nine-Month Extension, of the Safety and IOP-Lowering Efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% Compared to ALPHAGAN®P, 0.15% in Patients with Open-Angle Glaucoma or Ocular Hypertension.(C-02-49) Sponsor: Alcon Research Ltd, Sub-Investigator

A Comparative Study Of Blood Pressure Cuffs And Noninvasive Blood Pressure Monitors. Sponsor GE Medical Systems Information Technologies, Sub-Investigator

Multi-Purpose Solution Comparison Study: #352: Sponsor: Bausch & Lomb, Inc. Sub-Investigator